Aqua North Carolina, Inc. v. Corteva, Inc.

CourtDistrict Court, E.D. North Carolina
DecidedJuly 9, 2024
Docket7:23-cv-00016
StatusUnknown

This text of Aqua North Carolina, Inc. v. Corteva, Inc. (Aqua North Carolina, Inc. v. Corteva, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Aqua North Carolina, Inc. v. Corteva, Inc., (E.D.N.C. 2024).

Opinion

□ IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA SOUTHERN DIVISION No. 7:23-CV-16-D

AQUA NORTH CAROLINA, INC., ) Plaintiff, v. □ ORDER CORTEVA, INC., et al., Defendants.

On December 28, 2022, Aqua North Carolina, Inc. (“Aqua” or “plaintiff’) filed a complaint in New Hanover Superior Court against E.I. Du Pont de Nemours and Company, Inc. (“Du Pont”), the Chemours Company (“Chemours”), the Chemours Company FC, LLC (“Chemours FC”), and Corteva, Inc. (“Corteva”) (collectively “defendants”) alleging inadequate design or formulation, gross negligence, negligence, private nuisance, public nuisance, trespass to chattels and real property, actual fraudulent transfer, constructive fraudulent transfer, punitive damages, unjust enrichment, and unfair and deceptive trade practices. See [D.E. 1-4] 5-25. On February 2, 2023, defendants removed the case to this court [D.E. 1]. On September 8, 2023, Aqua filed an amended complaint [D.E. 36]. On September 21, 2023, □ the court notified Aqua of deficiencies and ordered Aqua to move to amend its complaint. On September 28, 2023, Aqua moved to amend its complaint [D.E. 43]. On October 2, 2023, the court granted Aqua’s motion to amend [D.E. 45]. On October 6, 2023, Aqua filed an amended complaint [D.E. 47].

On October 30, 2023, defendants moved to dismiss Aqua’s amended complaint for failure to state a claim [D.E. 49] and filed a memorandum in support [D.E. 50]. See Fed. R. Civ. P. 12(b)(6). On December 4, 2023, Aqua voluntarily dismissed its actual fraudulent transfer □□□ constructive fraudulent transfer claims [D.E. 52] and responded in opposition to defendants’ motion to dismiss [D.E. 53]. On December 18, 2023, defendants replied [D.E. 54]. ‘AS explained below, the court grants in part defendants’ motion to dismiss and dismisses Aqua’s inadequate design, public nuisance, trespass to chattels, punitive damages, and unfair and deceptive trade practices claims. L :

The Fayetteville Works Facility (“FWF”) produces films, fibers, and specialty chemicals. See Am. Compl. [D.E. 47] 432. Du Pont owned and operated FWF from the early 1970s until 2015, when Du Pont transferred ownership to Chemours, a spin-off. See id. at 3, 14. Chemours currently operates FWF. See id. at § 19. Chemours FC is a subsidiary of Chemours and also operates FWF. See id. at #[21—22. Through a series of transactions, Corteva holds certain Du Pont assets and liabilities. See id. at ff 25-28.

At one time, the 3M Company supplied a bio-persistent, bio-accumulative chemical, Perfluorooctanoic acid (“PFOA” or “C8”) to defendants. See id. at 429. PFOA is akind of per- or polyfluoroalkyl substance (“PFAS”). The 3M Company “decided to stop making” its own PFAS, so Du Pont “quietly increased its own production of PFOA at [FWF] located on the Cape Fear [R]iver in North Carolina.” Id. In 2006, the EPA formed a global stewardship program aimed at eliminating PFOA from emissions and products by 2015. See id. at { 30. In response, Du Pont developed GenX as a substitute for PFOA. See id. Defendants increased GenX production at FWF

over the ensuing years and claimed it was “a more sustainable solution” than PFOA. Id. Defendants also claimed GenX had “a favorable toxicological profile and very rapid bioelimination.” Id. Aqua alleges that defendants discharge wastewater from FWF, which allegedly contains polyfluorinated chemicals (“PFCs”) like GenX, into the Cape Fear River. See id. at J] 3, 32. Aqua alleges that FWF “has or had had at least one exhaust stack” that caused airborne emissions of PFCs, which caused “additional water contamination when airborne particles emitted from the stack” and dissolved or leached into groundwater. Id. at { 33. Defendants have studied the health effects of GenX since approximately 1963. See id. at J 42. Aqua alleges “Ts|cientists have linked PFCs to kidney cancer, testicular cancer, prostate cancer,

_ Ovarian cancer, non-Hodgkin lymphoma, liver disease, ulcerative colitis, thyroid disease, hypercholesterolemia, and pregnancy-induced hypertension.” Id. at § 34; see id. at ]42. Regulators and scientists “acknowledge substantial toxicological concerns and related human health and environmental risks posed by GenX and other PFCs.” Id. at { 45. Scientists base these results on animal studies. See id. at J] 42-43. Scientists have not conducted a “substantive body of human studies.” Id. at | 43. Despite the results of the animal studies, defendants “repeatedly failed to recover and capture (destroy) or recycle GenX from its wastewater.” Id. at ] 44. Instead, defendants “continued to discharge significant quantities of GenX into the [Cape Fear] River, the groundwater, and the air” surrounding FWF. Id. On February 25, 2019, Chemours and North Carolina signed a consent order that required Chemours to provide certain remedial measures, such as water filtration systems, to affected businesses, households, schools, and public buildings. See id. at | 47-50. On June 15, 2022, the Environmental Protection Agency (“EPA”) reduced its drinking water Health Advisory Level for GenX from 140 ppt to 10 ppt. See id. at J] 53-54.

Aqua is a water utility provider that serves over 320,000 North Carolinians across the state, including in New Hanover and counties allegedly affected by defendants’ wastewater. See id. at J 2. Aqua owns and operates 737 public water systems throughout North Carolina. See id. at □ 12. Aqua’s water systems “include over 1,500 active production wells and approximately 85,000 water connections.” Id. at | 13. Aqua alleges defendants have contaminated some of Aqua’s water systems through defendants’ discharge of GenX and other PFCs. See id. Aqua alleges that defendants’ discharge of GenX and PFCs has forced Aqua “to address the contamination of its water systems ... to protect its customers’ health and well-being and its infrastructure.” Id. at 739. Aqua alleges it has “expended and will continue to expend significant resources to sample, test, investigate, and monitor its water systems for PFC contamination.” Id. Aquaalso has “incurred, and will continue to incur, significant costs to moniter its water systems” for PFCs and improve its water systems with filtration systems to reduce or remove PFC contamination. Id. at J 40. I. A motion to dismiss under Rule 12(b)(6) tests the complaint’s legal and factual sufficiency. See Ashcroft v. Iqbal, 556 U.S. 662, 677-80 (2009); Bell Atl. Corp. v. Twombly, 550 U.S. 544, 554-63 (2007); Coleman v. Md. Ct. of Appeals, 626 F.3d 187, 190 (4th Cir. 2010), aff'd, 566 U.S. 30 (2012); Giarratano v. Johnson, 521 F.3d 298, 302 (4th Cir. 2008). To withstand a Rule 12(b)(6) motion, a pleading “must contain sufficient factual matter, accepted as true, to state a claim to relief that is plausible on its face.” Iqbal, 556 U.S. at 678 (quotation omitted); see Twombly, 550 U.S. at 570; Giarratano, 521 F.3d at 302. In considering the motion, the court must construe the facts and reasonable inferences “in the light most favorable to [the nonmoving party].” Massey v. Ojaniit, 759 F.3d 343, 352 (4th Cir. 2014) (quotation omitted); see Clatterbuck v. City of Charlottesville, 708 F.3d 549, 557 (4th Cir. 2013), abrogated on other grounds by Reed v. Town of Gilbert, 576 U.S. 155

(2015).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Day & Zimmermann, Inc. v. Challoner
423 U.S. 3 (Supreme Court, 1975)
Hicks Ex Rel. Feiock v. Feiock
485 U.S. 624 (Supreme Court, 1988)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Coleman v. Maryland Court of Appeals
626 F.3d 187 (Fourth Circuit, 2010)
Coleman v. Court of Appeals of Maryland
132 S. Ct. 1327 (Supreme Court, 2012)
Albert Clatterbuck v. City of Charlottesville
708 F.3d 549 (Fourth Circuit, 2013)
Giarratano v. Johnson
521 F.3d 298 (Fourth Circuit, 2008)
Philips v. Pitt County Memorial Hospital
572 F.3d 176 (Fourth Circuit, 2009)
Town of Nags Head v. Matthew Toloczko
728 F.3d 391 (Fourth Circuit, 2013)
Hawkins v. Hawkins
400 S.E.2d 472 (Court of Appeals of North Carolina, 1991)
Rainey v. St. Lawrence Homes, Inc.
621 S.E.2d 217 (Court of Appeals of North Carolina, 2005)
Red Hill Hosiery Mill, Inc. v. Magnetek, Inc.
530 S.E.2d 321 (Court of Appeals of North Carolina, 2000)
Keziah v. Seaboard Air Line Railroad Company
158 S.E.2d 539 (Supreme Court of North Carolina, 1968)

Cite This Page — Counsel Stack

Bluebook (online)
Aqua North Carolina, Inc. v. Corteva, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/aqua-north-carolina-inc-v-corteva-inc-nced-2024.